Targeting leukocyte migration and adhesion in Crohn’s disease and ulcerative colitis
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting leukocyte migration and adhesion in Crohn’s disease and ulcerative colitis
Authors
Keywords
-
Journal
INFLAMMOPHARMACOLOGY
Volume 20, Issue 1, Pages 1-18
Publisher
Springer Nature
Online
2011-12-19
DOI
10.1007/s10787-011-0104-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes
- (2011) EG Stefanich et al. BRITISH JOURNAL OF PHARMACOLOGY
- Tumor Necrosis Factor-α Monoclonal Antibodies in the Treatment of Inflammatory Bowel Disease: Clinical Practice Pharmacology
- (2010) Thomas W. Lee et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis
- (2010) Chen S Tan et al. LANCET NEUROLOGY
- The efficacy and safety of a third anti-TNF monoclonal antibody in Crohnâs disease after failure of two other anti-TNF antibodies
- (2009) M. ALLEZ et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Pharmacological characterization of PF-00547659, an anti-human MAdCAM monoclonal antibody
- (2009) N Pullen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Integrins
- (2009) Malgorzata Barczyk et al. CELL AND TISSUE RESEARCH
- M1647 An Orally Active Alpha4 Integrin Antagonist AJM300 Prevents the Development of Experimental Colitis Induced By Adoptive Transfer of IL-10 Deficient CD4+ T Cells in Mice
- (2009) Toshihiko Sugiura et al. GASTROENTEROLOGY
- S1066 Oral Alpha-4 Integrin Inhibitor (AJM300) in Patients with Active Crohn's Disease — A Randomized, Double-Blind, Placebo-Controlled Trial
- (2009) Masakazu Takazoe et al. GASTROENTEROLOGY
- The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti- 4 7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases
- (2009) D. Soler et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Decrease in the Numbers of Dendritic Cells and CD4+ T Cells in Cerebral Perivascular Spaces Due to Natalizumab
- (2008) Maria del Pilar Martin ARCHIVES OF NEUROLOGY
- The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans
- (2008) F. Zohren et al. BLOOD
- Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab
- (2008) H. Bonig et al. BLOOD
- Integrin E(CD103) 7 influences cellular shape and motility in a ligand-dependent fashion
- (2008) S. Schlickum et al. BLOOD
- Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin
- (2008) Brian G. Feagan et al. Clinical Gastroenterology and Hepatology
- Small intestinal CD103+dendritic cells display unique functional properties that are conserved between mice and humans
- (2008) Elin Jaensson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Homing imprinting and immunomodulation in the gut: Role of dendritic cells and retinoids
- (2007) Rodrigo J. Mora INFLAMMATORY BOWEL DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now